12 October 2021

safety alerts

Reference: CIR-2021-00000184

 

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

• Urgent Medical Device Recall Stem-Kit Reagents 50 Tests/ REF IM3630
• Safety Alerts for Medical Device LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests
• Lifting the Suspension on the Registration & Marketing of the Product • Diostart Plus 160-12.5 mg Tablets • Diostar Plus 160-25 mg Tablets • Diostar Plus 80-12.5 mg Tablets

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Stem-Kit Reagents 50 Tests تقارير سلامة لوسيلة طبية-1.pdf:

View Document

LeadCare II LeadCare expand recall تقارير سلامة لوسيلة طبية-1.pdf:

View Document

Diostar plus 80 160mg12.5mg tabletرفع تعليق.pdf:

View Document